Health Condition 1: I10- Essential (primary) hypertension
Conditions
Interventions
Intervention1: Morning dosing with daily mobile reminders: Antihypertensive medication administered in the morning at 8:00 AM with daily mobile reminders to improve medication adherence, for a duratio
Sponsors
Dr Harshad Venugopal Ramineni
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adults aged 18–65 years with a diagnosis of essential hypertension. 2. On stable once-daily antihypertensive therapy for at least 4 weeks. 3. Access to a smartphone with WhatsApp installed. 4. Giving written consent for participating in the trial.
Exclusion criteria
Exclusion criteria: 1. Secondary hypertension or hypertensive emergencies. 2. Comorbid conditions requiring complex drug regimens. 3. Non-compliance or inability to adhere to the protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean reduction in systolic and diastolic blood pressure (measured in mmHg).Timepoint: Baseline, 4 weeks, and 8 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Adherence to antihypertensive medication (measured using a validated scale like MMAS-8).Timepoint: Baseline, 4 weeks, and 8 weeks.;Participant satisfaction with the intervention (measured using a satisfaction survey or questionnaire).Timepoint: At the 8-week follow-up.;Incidence of adverse effects related to antihypertensive medications (e.g., dizziness, fatigue).Timepoint: Monitored throughout the 8-week trial period. | — |
Countries
India
Contacts
Public ContactDr A N Dattatri
Karnataka Medical College and Research Institute, Hubballi
Outcome results
None listed